Therapeutic potential of ADAR1-regulated macrophage exosomes for improving myocardial damage in septic cardiomyopathy
J Nanobiotechnology. 2026 Apr 11. doi: 10.1186/s12951-026-04368-4. Online ahead of print.ABSTRACTBACKGROUND: Sepsis-induced cardiomyopathy (SICM) is a critical cardiovascular complication characterized by cardiac dysfunction and high mortality. The molecular mechanisms that underlie SICM remain elus

